Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates: I. General teratogenicity

Andrew G Hendrickx, M. Pellegrini, R. Tarara, R. Parker, S. Silverman, A. J. Steffek

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Eighteen pregnant Macaca mulatta, 15 Macaca radiata, and six Papio cynocephalus were treated with 5–20 mg/kg triamcinolone acetonide (TAC) between 21 and 43 days of gestation on single‐ or multiple‐day treatment schedules. Prenatal deaths and stillbirths were tripled in the bonnet monkey and doubled in the rhesus monkey, but did not significantly increase in the baboon. The central nervous system and cranium were the most commonly malformed areas in all three species. The incidence of severe defects, e.g., cranium bifidum, encephalocele, meningocele, and hydrocephalus, was increased in multiple‐day treated cases. Minor abnormalities such as aplasia cutis congenita, cranium bifidum occultum, and occipital lobe hypoplasia were more prevalent in single‐day treated cases. The sensitive period (days 23–31) for TAC for this group of defects encompasses neural tube closure, rostral demarcation of the midbrain, and development of the primordial collicular plate and two midbrain neuromeres. The results of this study indicate that TAC is a valuable chemical tool for the study of malformations and pathogenesis of the brain and accompanying craniofacial defects.

Original languageEnglish (US)
Pages (from-to)103-114
Number of pages12
JournalTeratology
Volume22
Issue number1
DOIs
StatePublished - 1980

Fingerprint

Nervous System Malformations
Triamcinolone Acetonide
Neurology
Macaca radiata
Primates
Encephalocele
Central Nervous System
Mesencephalon
Macaca mulatta
Defects
Papio cynocephalus
Meningocele
Ectodermal Dysplasia
Occipital Lobe
Stillbirth
Neural Tube Defects
Papio
Hydrocephalus
Skull
Brain

ASJC Scopus subject areas

  • Embryology
  • Toxicology
  • Developmental Biology
  • Health, Toxicology and Mutagenesis

Cite this

Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates : I. General teratogenicity. / Hendrickx, Andrew G; Pellegrini, M.; Tarara, R.; Parker, R.; Silverman, S.; Steffek, A. J.

In: Teratology, Vol. 22, No. 1, 1980, p. 103-114.

Research output: Contribution to journalArticle

Hendrickx, Andrew G ; Pellegrini, M. ; Tarara, R. ; Parker, R. ; Silverman, S. ; Steffek, A. J. / Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates : I. General teratogenicity. In: Teratology. 1980 ; Vol. 22, No. 1. pp. 103-114.
@article{bd5439b949044727b4aa34e2e1098902,
title = "Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates: I. General teratogenicity",
abstract = "Eighteen pregnant Macaca mulatta, 15 Macaca radiata, and six Papio cynocephalus were treated with 5–20 mg/kg triamcinolone acetonide (TAC) between 21 and 43 days of gestation on single‐ or multiple‐day treatment schedules. Prenatal deaths and stillbirths were tripled in the bonnet monkey and doubled in the rhesus monkey, but did not significantly increase in the baboon. The central nervous system and cranium were the most commonly malformed areas in all three species. The incidence of severe defects, e.g., cranium bifidum, encephalocele, meningocele, and hydrocephalus, was increased in multiple‐day treated cases. Minor abnormalities such as aplasia cutis congenita, cranium bifidum occultum, and occipital lobe hypoplasia were more prevalent in single‐day treated cases. The sensitive period (days 23–31) for TAC for this group of defects encompasses neural tube closure, rostral demarcation of the midbrain, and development of the primordial collicular plate and two midbrain neuromeres. The results of this study indicate that TAC is a valuable chemical tool for the study of malformations and pathogenesis of the brain and accompanying craniofacial defects.",
author = "Hendrickx, {Andrew G} and M. Pellegrini and R. Tarara and R. Parker and S. Silverman and Steffek, {A. J.}",
year = "1980",
doi = "10.1002/tera.1420220113",
language = "English (US)",
volume = "22",
pages = "103--114",
journal = "Teratology",
issn = "1542-0752",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates

T2 - I. General teratogenicity

AU - Hendrickx, Andrew G

AU - Pellegrini, M.

AU - Tarara, R.

AU - Parker, R.

AU - Silverman, S.

AU - Steffek, A. J.

PY - 1980

Y1 - 1980

N2 - Eighteen pregnant Macaca mulatta, 15 Macaca radiata, and six Papio cynocephalus were treated with 5–20 mg/kg triamcinolone acetonide (TAC) between 21 and 43 days of gestation on single‐ or multiple‐day treatment schedules. Prenatal deaths and stillbirths were tripled in the bonnet monkey and doubled in the rhesus monkey, but did not significantly increase in the baboon. The central nervous system and cranium were the most commonly malformed areas in all three species. The incidence of severe defects, e.g., cranium bifidum, encephalocele, meningocele, and hydrocephalus, was increased in multiple‐day treated cases. Minor abnormalities such as aplasia cutis congenita, cranium bifidum occultum, and occipital lobe hypoplasia were more prevalent in single‐day treated cases. The sensitive period (days 23–31) for TAC for this group of defects encompasses neural tube closure, rostral demarcation of the midbrain, and development of the primordial collicular plate and two midbrain neuromeres. The results of this study indicate that TAC is a valuable chemical tool for the study of malformations and pathogenesis of the brain and accompanying craniofacial defects.

AB - Eighteen pregnant Macaca mulatta, 15 Macaca radiata, and six Papio cynocephalus were treated with 5–20 mg/kg triamcinolone acetonide (TAC) between 21 and 43 days of gestation on single‐ or multiple‐day treatment schedules. Prenatal deaths and stillbirths were tripled in the bonnet monkey and doubled in the rhesus monkey, but did not significantly increase in the baboon. The central nervous system and cranium were the most commonly malformed areas in all three species. The incidence of severe defects, e.g., cranium bifidum, encephalocele, meningocele, and hydrocephalus, was increased in multiple‐day treated cases. Minor abnormalities such as aplasia cutis congenita, cranium bifidum occultum, and occipital lobe hypoplasia were more prevalent in single‐day treated cases. The sensitive period (days 23–31) for TAC for this group of defects encompasses neural tube closure, rostral demarcation of the midbrain, and development of the primordial collicular plate and two midbrain neuromeres. The results of this study indicate that TAC is a valuable chemical tool for the study of malformations and pathogenesis of the brain and accompanying craniofacial defects.

UR - http://www.scopus.com/inward/record.url?scp=0018939013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018939013&partnerID=8YFLogxK

U2 - 10.1002/tera.1420220113

DO - 10.1002/tera.1420220113

M3 - Article

C2 - 7444796

AN - SCOPUS:0018939013

VL - 22

SP - 103

EP - 114

JO - Teratology

JF - Teratology

SN - 1542-0752

IS - 1

ER -